|
1
|
Bosch FX, Ribes J, Díaz M and Cléries R:
Primary liver cancer: Worldwide incidence and trends.
Gastroenterology. 127 (Suppl 1):S5–S16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pisani P, Parkin DM, Bray F and Ferlay J:
Estimates of the worldwide mortality from 25 cancers in 1990. Int J
Cancer. 83:18–29. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pinter M and Peck-Radosavljevic M: Review
article: Systemic treatment of hepatocellular carcinoma. Aliment
Pharm Ther. 48:598–609. 2018. View Article : Google Scholar
|
|
6
|
Abdel-Rahman O and Lamarca A: Development
of sorafenib-related side effects in patients diagnosed with
advanced hepatocellular carcinoma treated with sorafenib: A
systematic-review and meta-analysis of the impact on survival.
Expert Rev Gastroenterol Hepatol. 11:75–83. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Imenshahidi M and Hosseinzadeh H: Berberis
vulgaris and berberine: An update review. Phytother Res.
30:1745–1764. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Wang X, Sha S, Liang S, Zhao L,
Liu L, Chai N, Wang H and Wu K: Berberine increases the expression
of NHE3 and AQP4 in sennosideA-induced diarrhoea model.
Fitoterapia. 83:1014–1022. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Yu H, Zhang C, Cheng Y, Hu L, Meng
X and Zhao Y: Protective effects of berberine on radiation-induced
lung injury via intercellular adhesion molecular-1 and transforming
growth factor-beta-1 in patients with lung cancer. Eur J Cancer.
44:2425–2432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rezaeiamiri E, Bahramsoltani R and Rahimi
R: Plant-derived natural agents as dietary supplements for the
regulation of glycosylated hemoglobin: A review of clinical trials.
Clin Nutr. Feb 10–2019.(Epub ahead of print). doi:
10.1016/j.clnu.2019.02.006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tillhon M, Guamán Ortiz LM, Lombardi P and
Scovassi AI: Berberine: New perspectives for old remedies. Biochem
Pharmacol. 84:1260–1267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin P, Zhang C and Li N: Berberine
exhibits antitumor effects in human ovarian cancer cells.
Anticancer Agents Med Chem. 15:511–516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pierpaoli E, Arcamone AG, Buzzetti F,
Lombardi P, Salvatore C and Provinciali M: Antitumor effect of
novel berberine derivatives in breast cancer cells. Biofactors.
39:672–679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li CH, Wu DF, Ding H, Zhao Y, Zhou KY and
Xu DE: Berberine hydrochloride impact on physiological processes
and modulation of twist levels in nasopharyngeal carcinoma CNE-1
cells. Asian Pac J Cancer Prev. 15:1851–1857. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li L, Wang X, Sharvan R, Gao J and Qu S:
Berberine could inhibit thyroid carcinoma cells by inducing
mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing
migration via PI3K-AKT and MAPK signaling pathways. Biomed
Pharmacother. 95:1225–1231. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Q, Zhang C, Yang X, Yang B, Wang J,
Kang Y, Wang Z, Li D, Huang G, Ma Z, et al: Berberine inhibits the
expression of hypoxia induction factor-1alpha and increases the
radiosensitivity of prostate cancer. Diagn Pathol. 9:982014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kou Y, Li L, Li H, Tan Y, Li B, Wang K and
Du B: Berberine suppressed epithelial mesenchymal transition
through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma
cells. Biochem Biophys Res Commun. 479:290–296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo P, Cai C, Wu X, Fan X, Huang W, Zhou
J, Wu Q, Huang Y, Zhao W, Zhang F, et al: An insight into the
molecular mechanism of berberine towards multiple cancer types
through systems pharmacology. Front Pharmacol. 10:8572019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hao DC and Xiao PG: Network pharmacology:
A Rosetta stone for traditional Chinese medicine. Drug Develop Res.
75:299–312. 2014. View Article : Google Scholar
|
|
20
|
Zoete V, Grosdidier A and Michielin O:
Docking, virtual high throughput screening and in silico
fragment-based drug design. J Cell Mol Med. 13:238–248. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ru J, Li P, Wang J, Zhou W, Li B, Huang C,
Li P, Guo Z, Tao W, Yang Y, et al: TCMSP: A database of systems
pharmacology for drug discovery from herbal medicines. J
Cheminform. 6:132014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu X, Ouyang S, Yu B, Liu Y, Huang K,
Gong J, Zheng S, Li Z, Li H and Jiang H: PharmMapper server: A web
server for potential drug target identification using pharmacophore
mapping approach. Nucleic Acids Res. 38:W609–W614. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu H, Chen J, Xu X, Li Y, Zhao H, Fang Y,
Li X, Zhou W, Wang W and Wang Y: A systematic prediction of
multiple drug-target interactions from chemical, genomic and
pharmacological data. PLoS One. 7:e376082012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Su WH, Chao CC, Yeh SH, Chen DS, Chen PJ
and Jou YS: OncoDB.HCC: An integrated oncogenomic database of
hepatocellular carcinoma revealed aberrant cancer target genes and
loci. Nucleic Acids Res. 35:D727–D731. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang DW, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang DW, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chuang CH, Cheng TC, Leu YL, Chuang KH,
Tzou SC and Chen CS: Discovery of Akt kinase inhibitors through
Structure-Based virtual screening and their evaluation as potential
anticancer agents. Int J Mol Sci. 16:3202–3212. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Renata DP, Christian VQ, Ruiz DD, Gargano
F and de Souza ON: A selective method for optimizing ensemble
docking-based experiments on an InhA Fully-Flexible receptor model.
BMC Bioinformatics. 19:2352018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Li X, Huang J and Liu Y: Matrix
metalloproteinase 2 knockdown suppresses the proliferation of HepG2
and Huh7 cells and enhances the cisplatin effect. Open Med (Wars).
14:384–391. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu C, Zhang W, Zhang X, Zhou D, Qu L, Liu
J, Xiao M, Ni R, Jiang F, Ni W and Lu C: Coupling function of
cyclin-dependent kinase 2 and Septin2 in the promotion of
hepatocellular carcinoma. Cancer Sci. 110:540–549. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hong M, Li S, Wang N, Tan HY, Cheung F and
Feng Y: A biomedical investigation of the hepatoprotective effect
of radix salviae miltiorrhizae and network Pharmacology-Based
prediction of the active compounds and molecular targets. Int J Mol
Sci. 18:E6202017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hong M, Li S, Tan H, Cheung F, Wang N,
Huang J and Feng Y: A Network-Based pharmacology study of the
Herb-induced liver injury potential of traditional hepatoprotective
Chinese herbal medicines. Molecules. 22:E6322017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang X, Wang N, Li H, Liu M, Cao F, Yu X,
Zhang J, Tan Y, Xiang L and Feng Y: Up-Regulation of PAI-1 and
Down-regulation of uPA are involved in suppression of invasiveness
and motility of hepatocellular carcinoma cells by a natural
compound berberine. Int J Mol Sci. 17:5772016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang N, Feng Y, Zhu M, Tsang CM, Man K,
Tong Y and Tsao SW: Berberine induces autophagic cell death and
mitochondrial apoptosis in liver cancer cells: The cellular
mechanism. J Cell Biochem. 111:1426–1436. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cantley LC and Neel BG: New insights into
tumor suppression: PTEN suppresses tumor formation by restraining
the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA.
96:4240–4245. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Manning BD and Toker A: AKT/PKB signaling:
Navigating the network. Cell. 169:381–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Courtney KD, Corcoran RB and Engelman JA:
The PI3K pathway as drug target in human cancer. J Clin Oncol.
28:1075–1083. 2010. View Article : Google Scholar : PubMed/NCBI
|
